Listed

ImmunityBio, Inc.: Form 10-K for the period ended Dec 31, 2016

Filed with the SEC on Mar 15, 2017 and accepted by EDGAR at Mar 15, 2017, 16:17 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2016-10-01 to 2016-12-31$14.0kus-gaap:Revenues
Revenue12 months2016-01-01 to 2016-12-31$44.0kus-gaap:Revenues
Research and development12 months2016-01-01 to 2016-12-31$29.2mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative12 months2016-01-01 to 2016-12-31$95.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2016-10-01 to 2016-12-31−$25.1mus-gaap:OperatingIncomeLoss
Operating income12 months2016-01-01 to 2016-12-31−$124.5mus-gaap:OperatingIncomeLoss
Interest expense12 months2016-01-01 to 2016-12-31$66.0kus-gaap:InterestExpense
Income tax12 months2016-01-01 to 2016-12-31−$572.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2016-10-01 to 2016-12-31−$24.2mus-gaap:NetIncomeLoss
Net income12 months2016-01-01 to 2016-12-31−$120.8mus-gaap:NetIncomeLoss
Diluted EPS3 months2016-10-01 to 2016-12-31−$0.29us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS12 months2016-01-01 to 2016-12-31−$1.47us-gaap:EarningsPerShareBasicAndDiluted
Capital expenditure12 months2016-01-01 to 2016-12-31$6.6mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases12 months2016-01-01 to 2016-12-31$15.8mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2016-12-31$8.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-12-31$205.1mus-gaap:AssetsCurrent
Total assetsAt period end2016-12-31$317.5mus-gaap:Assets
Current liabilitiesAt period end2016-12-31$12.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-12-31$24.1mus-gaap:Liabilities
Shareholders' equityAt period end2016-12-31$293.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-17-004430. Last ingested by Listed: Nov 9, 2026, 17:45 ET. Listed shows no prices and gives no investment advice.